168 related articles for article (PubMed ID: 15554388)
1. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.
Matsuda A; Higashi M; Nakagawa T; Yokoyama S; Kuno A; Yonezawa S; Narimatsu H
Lab Invest; 2017 Sep; 97(9):1103-1113. PubMed ID: 28581490
[TBL] [Abstract][Full Text] [Related]
6. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
8. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
9. A novel monoclonal antibody specific for sialylated MUC1 mucin.
Yamamoto M; Bhavanandan VP; Nakamori S; Irimura T
Jpn J Cancer Res; 1996 May; 87(5):488-96. PubMed ID: 8641986
[TBL] [Abstract][Full Text] [Related]
10. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
12. MUC1 expression in colorectal carcinoma: Clinicopathological correlation and prognostic significance.
Díaz Del Arco C; Garré P; Molina Roldán E; Lorca V; Cerón Nieto MÁ; Fernández Aceñero MJ
Rev Esp Patol; 2018; 51(4):204-209. PubMed ID: 30269770
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
[TBL] [Abstract][Full Text] [Related]
15. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.
Yamato T; Sasaki M; Watanabe Y; Nakanuma Y
J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of MUC1 extracellular domain in breast, head and neck, and colon cancer.
Rabassa ME; Larrain MT; Lacunza E; Cermignani L; Alberdi CG; Demichelis SO; Abba MC; Segal-Eiras A; Croce MV
Int J Biol Markers; 2015 Jul; 30(3):e294-300. PubMed ID: 25982681
[TBL] [Abstract][Full Text] [Related]
17.
Kokubu R; Ohno S; Kuratani H; Takahashi Y; Manabe N; Shimizu H; Chiba Y; Denda-Nagai K; Tsuiji M; Irimura T; Yamaguchi Y
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887202
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
20. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.
Sato K; Mori R; Hiroshima Y; Oba MS; Matsuyama R; Bouvet M; Hoffman RM; Endo I
J Surg Res; 2018 Jun; 226():122-130. PubMed ID: 29661277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
